iBio, Inc.

IBIO · NASDAQ
Analyze with AI
6/30/2025
6/30/2024
6/30/2023
6/30/2022
Operating Activities
Net Income-$18-$25-$65-$30
Dep. & Amort.$0$1$1$4
Deferred Tax$0$0$0$0
Stock-Based Comp.$2$2$4$0
Change in WC$0-$3$6$3
Other Non-Cash$1$6$23-$15
Operating Cash Flow-$15-$19-$30-$38
Investing Activities
PP&E Inv.-$0-$0-$6-$12
Net Acquisitions$0$0-$1$0
Inv. Purchases$0$0$0-$7
Inv. Sales/Matur.$0$0$11$14
Other Inv. Act.$1$1$3$0
Investing Cash Flow$1$1$7-$5
Financing Activities
Debt Repay.-$1-$1-$9-$6
Stock Issued$10$26$11$0
Stock Repurch.$0-$0-$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0-$0-$0
Financing Cash Flow$9$24$2-$6
Forex Effect$0$0$0-$6
Net Chg. in Cash-$6$7-$21-$55
Supplemental Information
Beg. Cash$14$8$29$77
End Cash$9$14$8$23
Free Cash Flow-$15-$19-$36-$45
iBio, Inc. (IBIO) Financial Statements & Key Stats | AlphaPilot